Abstract. a-mannosidases I and II (Man I and 11) are resident enzymes of the Golgi complex involved in oligosaccharide processing during N-linked glycoprotein biosynthesis that are widely considered to be markers of the cis-and medial-Golgi compartments, respectively. We have investigated the distribution of these enzymes in several cell types by immunofluorescence and immunoelectron microscopy. Man 1I was most commonly found in medial-and/or trans-cisternae but showed cell type-dependent variations in intra-Golgi distribution. It was variously localized to either medial (NRK and CHO ceils), both medial and trans (pancreatic acinar cells, enterocytes), or trans-(goblet ceils) cisternae, or distributed across the entire Golgi stack (hepatocytes and some enterocytes). The distribution of Man I largely coincided with that of Man II in that it was detected primarily in medialand trans-cisternae. It also showed cell type dependent variations in its intra-Golgi distribution. Man I and Man II were also detected within secretory granules and at the cell surface of some cell types (enterocytes, pancreatic acinar cells, goblet cells). In the case of Man II, cell surface staining was shown not to be due to antibody cross-reactivity with oligosaccharide epitopes. These results indicate that the distribution of Man I and Man II within the Golgi stack of a given cell type overlaps considerably, and their distribution from one cell type to another is more variable and less compartmentalized than previously assumed.
I
NHERENT to current models of the Golgi complex is that it is both polarized and compartmentalized (11, 15, 16, 20, 22, 39) . The evidence for compartmentalization is based on immunocytochemical and biochemical (cell fractionation) findings on the distribution within the Golgi complex of enzymes involved in the synthesis and modification of N-linked glycoproteins (reviewed in [15] [16] [17] . Three functionally distinct compartments have been envisaged based on their ability to be separated from one another on sucrose density gradients. These consist of a light fraction containing the late acting Golgi enzymes, galactosyl-and sialytransferase, and a denser one containing the earlier acting enzymes a-mannosidase H (Man ID t and GIcNAc transferase I (11, 13, 14, 18) . These fractions were assumed to correspond to trans-and medial-Golgi elements, respectively, because galactosyl-and sialyltransferase have been localized by immunocytochemistry to trans-cisternae and the trans-Golgi network (TGN) (40, 42) , and GIcNAc transferase I has been similarly localized to medial-Gol~ cisternae (14) . A third fraction, heavier than the other two, was found to contain GIcNAc phosphotransferase and GIcNAc phosphodiesterase, the enzymes that generate the mannose-6-phosphate recognition marker on lysosomal enzymes (18) . Based on its high density this compartment was believed to correspond to the cis-Golgi cisternae. Mannosidase I (Man I) has also been assumed to reside in the cis-Gol~, because it acts on oligosaccharides of proteins that have just left the ER (1). However, none of these earlier acting enzymes have yet been localized within the Golgi stack by immunocytochemistry. In fact relatively few Golgi enzymes have been localized to date due to the fact that relatively few antibodies have been generated that are suitable for such purposes (17) .
In this paper we have localized by immunoelectron microscopy two Golgi enzymes-Man I and H-that are thought to represent markers for the cis-and medial-Golgi compartments, respectively. Man I is the enzyme that modifies Mang~-6GlcNAc2 oligosaccharides that enter the Golgi complex (53, 55, 56) to produce the transient endoglycosidase D-sensitive structure MansGlcNAc2 (27) .
Man II modifies the GIcNAcMansGlcNAc2 intermediate to complete the mannose trimming reactions and gives rise to the endoglycosidase H (endo H)-resistant oligosaccharide, GIcNAcMan3GlcNAc2 (30, 52, 56) . At present information on the localization of these enzymes within the Golgi stack is conflicting. Studies in which the glycosylation of VSV G protein has been followed in vitro have supported the idea that both Man I and II are located in the proximal (cis/medial) rather than the more distal (trans, TGN) region of the Golgi (1, 4, 5, 45) . In a previous immunocytochemical study it was reported that Man II has a broad distribution across the Golgi stack in hepatocytes (34); however, it was localized to cis-and medial-cisternae in rat basophilic leukemia (RBL) cells (23) and BHK cells (3, 8) . It is not clear whether these differences are due to differences in the methods or antibodies used or if they represent true variations from one cell type to the other. Our present results indicate that the distribution of both Man I and II in the Golgi complex is both variable and cell type-specific, but most often the two enzymes are localized together in medial-and/or trans-cisternae. These results are in keeping with other recent immunocytochemical evidence indicating that Golgi compartmentalization is more variable and less rigid than often assumed (6, 33, 36, 39) .
Cell Culture Y'3-Agl.2.3 rat myeloma cells were obtained from American Type Culture Collection (Rockville, MD) (CRL 1631) and cultured in high glucose DME with 2 mM L-glutamine, 50 U/ml penicillin, and 50/xg/ml streptomycin, 10% (vol/vol) FCS. Normal rat kidney (NRK) cells were cultured in this same medium supplemented with 2.5 % (vol/vot) FCS, and 2.5 % (vol/vol) newborn calf serum. CHO K1 cells were cultured in Ham's F12 medium containing 10% (vol/vol) FCS, 2 mM L-glutamine, and antibiotics.
Immunolabeling
Indirect immunofluorescence was carried out on cultured cells on coverslips or on semithin (1/~m) cryosections cut on a microtome equipped with an FC-4 cryoattachment (Reichert Jung, Vienna). Cultured cells were fixed with 2% paraformaldehyde in phosphate buffer, pH 7.4, and permeabilized with 0.1% Triton X-100. They were then rinsed, blocked with PBS/I% BSA, and incubated with primary antibody (1-2 h at room temperature) and with FITC-conjngated secondary antibodies (1 h). Semithin cryosections were similarly stained, except that some sections were partially deglycosylated by incubation with 2 M NaBI-h in 0.1 M NaOH at 37°C for 6 h. Section deglycosylation was monitored by assessing the disappearance of FITCwheat germ agglutinin staining.
For immunoperoxidase, cultured cells were fixed in periodate-lysineparaformaldehyde fixative for 4 h at room temperature (7) . Fixed cells were permeabilized with 0.005% saponin in PBS/0.5 % BSA and sequentially incubated with primary antibodies and HRP-conjugated secondary antibodies
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Materials
Fab fragments of goat anti-rabbit IgG conjugated to HRP were purchased from Biosys (Compi~'gne, France), F(ab')2 fragments of goat anti-rabbit IgG conjugated to FITC were purchased from TAGO (Burlingame, CA). 5 nm gold, goat anti-rabbit conjugate was obtained from Amersham Corp. (Arlington Heights, IL). Protein A and Sephadex G-25 columns were from Pharmacia Fine Chemicals (Piscataway, NJ). FITC-WGA, saponin, and BSA were obtained from Sigma Immunochemicals (St. Louis, MO). N-glycanase was from Genzyme (Cambridge, MA). Tissue culture reagents were obtained from GIBCO BRL (Gaithersburg, MD). PVDF was purchased from Millipore Continental Water Systems (Bedford, MA).
Antibodies
Anti-Man H. The catalytic domain of Golgi Man U was purified as described (32) and used to immunize a rabbit. The specificity of this antibody is the same as described for a previous polyclonal antibody raised against the intact enzyme (30) which was shown to immunoprecipitate Man II (124,000 mol wt) from rat liver, 3T3 cells and Hela cells, and to be distinct from both lysosomai and cytosolic c~-v-mannosidases and Golgi ~-Man IA and IB.
Anti-Man L Rabbit polyclonai antibody against Golgi Man I purified from rat liver has been previously characterized (55) . This antibody recognizes a 58-kD doublet on immunoblots of total microsomal proteins from both rat liver and pancreas, and quantitatively precipitates both Man IA and IB activities. It is therefore referred to as Man I antibody. It does not crossreact with other ct-v-mannosidases such as cytosolic or lysosomal mannosidases, or Golgi Man II (55) . The antibody (IgG fraction) was found to show cross-reactivity to fibronectin and was subsequently affinity depleted of cross-reactivity by passing it through a fibronectin-Sepharose 4B column.
Preparation of Antibodies to Deglycosylated Man H
1 nag of protein A-purified IgG was incubated with 30 ~g N-glycanase deglycosylated Man II which had been electrophoretically transferred to a polyvinylidene difluoride membrane. The membrane was washed with 0.5 M NaCI, 10 mM Tris, pH 8.0, 5 mM EDTA buffer, and the bound IgG fraction was eluted with two rinses (0.5 ml, 1 min) of 1 M propionic acid (pH 2.3) containing 0.5% BSA, followed by two rinses (0.5 ml, 1 rain) 1.5 M potassium thiocyanate. The einant was neutralized and desalted by immediate application to a Sephadex G-25 column, concentrated on a Centricon 30 membrane, and dialyzed against PBS containing 50% glycerol. diluted in the same buffer. They were then fixed with 2% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4, for 30 rain, and then processed for immunoperoxidase (7).
For immunogold labeling rat tissues were fixed in 3 % formaldehyde (freshly prepared from paraformaldehyde) and 0.1% glutaraldehyde in PBS for 1 h at room temperature. After blocking free aldehyde groups with 50 mM NH4CI for 30 rain, the tissue fragments were embedded at -35°C in Lowicryl K4M (41) . Alternatively, tissue pieces were fixed for 1 h in 3 % formaldehyde, 0.05% glutaraldehyde in 0.1 M eacodylate-HC1 buffer, pH 7.4, infiltrated with a mixture of 50% polyvinylpyrrolidone and 2.3 M sucrose, and processed for ultracryomicrotomy (54) . Immanogold labeling was carried out in some cases on plastic (Lowicryl)-embedded sections and in others on ultrathin cryosections. Ultrathin sections were cut from l.x)wicryl-embedded tissue, incubated with primary antibody followed by 8 nm protein A-gold complexes prepared by the tannic acid method (48) . Ultrathin cryosections were prepared (54) incubated with primary antibody followed by 5 nm gold, goat anti-rabbit conjugate. Labeled Lowicryl sections were stained with uranyl acetate followed by lead citrate, and labeled ultrathin cryosections were absorption stained with 0.2 % methyl cellulose, and 2.2% polyvinyl alcohol (54) .
Results
Man I and Man H Are Localized to the Golgi Region in Cultured Cells
By immunofluorescence both Man I and Man II were concentrated in the Golgi region of NRK ( Fig. 1 ) and CHO cells (not shown). These enzymes were not detected at the cell surface or in any other cell organelle. In the case of Man II a wide variety of cell lines were tested, including COS cells, murine erythroleukemia (MEL) cells, 3"1"3 cells, rat embryonic fibroblasts, AtT-20 pituitary cells, and GH3 pituitary cells, with the same results. Thus our findings verify the usefulness of Man H as an intracellular Golgi "marker" in cultured cell lines. In specialized cells in situ, Man I and Man II (Fig. 2, a and b) were found in the Golgi region, but were also present at the cell surface (see below).
The Distribution of Man H within the Golgi Stack Varies among Different Cell ~jpes
In NRK (Fig. 3 a) and CHO cells (Fig. 3, b and c) , Man II was localized in two to three med/al-Golgi cisternae sandwiched between one to two nonreactive eisternae on each side. In other cell types it had a different distribution: It was detected in both medial-and trans-cisternae in pancreatic acinar cells (Fig. 4 a) , exclusively in trans-cistemae in goblet cells of both duodenum (Fig. 5 a) and colon (Fig. 5 b), in medial-and trans-cisternae and the TGN in duodenal enterocytes (Fig. 5, c and d) , and all across the Golgi stack in hepatocytes (Fig. 6) , and some enterocytes (Fig. 5 e) . It was also detected on the membranes and in some cases Figure 5 . Distribution of Man II across the G-olgi complex of intestinal epithelial cells. In goblet cells of both duodenum (a) and colon (b) Man II is exclusively localized in the tmns-Golgi eisternae and the lumen of mucin droplets (rod), especially those newly derived from the trans side of the Golgi stack. No labeling of cis (cs) cisternae is seen. In enterocytes (c-e), Man II is detected in the TGN (tn) and two to three cisternae on the trans side of the Golgi stack; occasionally, the cis-cisternae (arrows) are also reactive (e). Lowicryl K4M thin sections stained with anti-Man II and protein A-gold. Bar, 0.25 #m.
within the contents of secretory granules/vesicles, i.e., condensing vacuoles and zymogen granules of exocrine pancreas (Fig. 4 a) , secretory vesicles of hepatocytes (Fig. 6, a  and b) , and mucin droplets of goblet cells (Fig. 5, a and b) .
These results indicate that Man II is found predominantly in medial-and/or tmns-cisternae in the majority of cell types, but its precise distribution within the Golgi stack varies from one cell type to another. Figure 6 . Distribution of Man II in the Golgi complex of hepatocytes. Immunogold labeling is predominantly found at the rims (large arrows) of the trans-Golgi cisternae, the TGN (tn), and secretory vesicles (v). It is also detected, although with less intensity, in association with cis and medial-Golgi cisternae (small arrows). Thin sections were obtained from Lowicryl-embedded rat liver. Bar, 0.25 pro.
The Distribution of Man I within the Golgi Overlaps with That of Man H
The distribution of Man I within the Golgi also varied. It was concentrated in the trans-cisternae and the TGN in NRK cells (Fig. 7, e-g ) and in medial-and trans-cisternae of enterocytes (Fig. 8, e and f ) . Occasionally, the enzyme extended more broadly in the cis-direction, i.e., including the medial-cisternae of NRK (Fig. 7 h ) and goblet cells (Fig. 8,  a and b) and cis-cisternae of enterocytes (Fig. 8 g) . It was also found all across the Golgi stack in pancreatic acinar cells (Fig. 9) , rat Y3-Agl.2.3 myeloma cells (Fig. 7, a-c (Table I) . As in the case of Man II, labeling for Man I was also present in secretory granules/vesicles of pancreatic acinar cells (Fig. 9 ) and goblet cells from both duodenum (Fig.  8, a and b) and colon (Fig. 8, c and d) . It can be concluded that Man I, like Man II, is concentrated primarily in medialand trans-Golgi subcompartments where it overlaps and largely coincides with the distribution of Man II.
Man I and Man H A r e Found at the Cell Surface in Some Cell 73~pes
In several specialized cell types, i.e., pancreatic acinar cells and enterocytes, both Man II (Figs. 2 and 10 ) and Man I (Fig.  11) were found along the plasma membrane as well as associated with Golgi membranes. Both the apical and basolateral plasma membrane domains of enterocytes and pancreatic acinar cells were labeled with both Man I (Fig.  11 ) and Man II (Fig. 2) antibodies. Labeling was particularly intense at the apical surface with numerous gold particles delineating the membrane of the microvilli in both duodenum (Figs. 10 a and 11, a-c) and colon (Fig. 11 d) . There was also significant labeling of the lateral surfaces (Fig. 11  a) , but the staining was lower on the basal surface in contact with the basement membrane (Fig. 11 c) .
To rule out that staining was due to reactivity of the antibody with carbohydrate epitopes, Man 1I antibody that had been affinity purified on deglycosylated Man II (Figs. 2, c' and d', and 10) or deglycosylated tissue sections (not shown) were used. Under such circumstances staining of the plasma membrane was reduced but not eliminated. These results indicate that although some of the cell surface staining obtained with antibody raised against Man II may be due to cross-reactivity with carbohydrate epitopes, the majority of the staining is due to reactivity against epitopes present within the polypeptide. It can be concluded that Man I and II are expressed at the cell surface in some cell types.
Discussion
Man I and H Are Not Segregated into Separate and Distinct Golgi Subcompartments
We have used immunofluorescence, immunoperoxidase, and immunogold techniques to localize Man I and II, two key enzymes in the biosynthesis of N-linked glycoproteins, which are widely believed to represent markers for the cis-and medial-Golgi subcompartments, respectively. Our immunolocalizations in a variety of cell types indicate that Man I and II: (a) exhibit cell type-dependent variations in their Golgi distribution; and (b) are not rigidly segregated from one another. Rather, the two enzymes overlap considerably, and both enzymes are concentrated in medial-and/or transcisternae of cell types examined. We recognize that while immunocytochemical techniques allow the proteins to be localized in precise Golgi subcompartments, we may detect only the sites of major concentrations of the enzymes and may fail to detect lower concentrations. Also, the sites of maximal enzyme activity may not be precisely coincident with the sites of maximal enzyme concentration identified by immunocytochemistry. It is possible, however, to compare different distribution patterns that may correspond to different Golgi subeompartmentalization of the N-glycosylation reactions and to conclude that there is considerable overlap in the distribution of these two enzymes.
Differences in Distribution of Golgi Enzymes among Different Cell ~ypes
We have found considerable variation in the distribution of Man I and Man II from one cell type to another. Cell type-specific differences in Golgi distribution have also been reported for two terminal glycosyltransferases, ot2,6 sialyltransferase and blood group A cd,3 N-acetylgalactosaminyltransferase. These enzymes and their glycosylation products have been found to be differentially distributed in the Golgi complex of adjacent intestinal goblet ceils and enterocytes (43) . In addition, there are reports of endogenous proteins in the cis- (58) and medial- (19) Golgi cisternae that bear terminal N-linked oligosaccharide modifications, suggesting either that they are exposed to the terminal transferases at their site of residence or that they traverse the stack and acquire terminal modifications in the trans compartments and are then targeted back to earlier Golgi compartments. Our observations support the concepts that: (a) the cisternal localization of Golgi enzymes involved in the processing of N-glycoproteins differs in different cell types (19, 43) ; and (b) there is considerable overlap in the distribution of glycoprotein processing enzymes among Golgi subcompartments.
Moreover, as indicated by the variable distribution of both Man I and Man II in enterocytes or Man I in rat myeloma and NRK cells, some variations in the distribution of these enzymes in the Golgi complex may occur within the same cell type. This suggests that Golgi compartmentalization of N-glycosylation processing enzymes may be influenced by other factors such as the functional state of the cell. For instance, Golgi distribution of certain cytochemical markers is known to be affected by cell differentiation (10, 35, 36) or by hyperstimulation (49) . 
Man I and H A r e Concentrated in Medial/Trans Cisternae in Most Cell T)lpes
Man I is the earliest acting of the Golgi enzymes that modify N-linked glycoproteins (52, 55, 56) . It cleaves the Mang~.tGlcNAc2 oligosaccharide to give rise to the endo D-sensitive MansGlcNAc2 structure. Although it has not been previously localized by immunoclectron microscopy, it has been assumed by some to be a cis-Golgi marker. Furthermore, appearance of endo D-sensitive glycoproteins during biosynthesis has often been taken as indication of transport of the glycoprotein to the cis-cisternae of the Golgi complex (1, 4, 5) . This is in spite of the fact that: (a) Man I and II activities cannot be resolved from one another in an in vitro transport system (45) ; and (b) the two enzymes comigrate on sucrose density gradients (11, 12, 13) . We found that in some of the cell types we have studied Man I is concentrated either exclusively in the trans-Golgi cisternae (goblet cells) or in both medial-and trans-Golgi cisternae (enterocytes, pancreatic acinar, and NRK cells) ( Table I) .
Man II cleaves the GlcNAcMan~GlcNAc2 oligosaccharide to produce the endo H-resistant structure, GIcNAcMan3GlcNAc~ (52, 56) . Due to the availability of excellent polyclonal (30) and monoclonal (3, 8) anti-Man II antibodies, this enzyme has been widely used as a Golgi marker in immunofluorescence assays (e.g., see references 21, 23, 38) . This enzyme was previously localized by immunoelectron microscopy across the Golgi stack of hepatocytes (34) , in the medial-Golgi cisternae of both BHK and NRK cells (3, 8) , and in cis-and medial-cisternae of RBL cells (23) . Based on biochemical findings, it was recently proposed that Man II is also present in the cis-Golgi compartment (45) . Our immunocytochemical observations indicate that Man II, like Man I, is concentrated in different regions of the Golgi cornplex depending on the cell type but is predominantly concentrated in medial-and trans-Golgi subcompartments where its distribution overlaps with that of Man I. Golgi localization of both mannosidases in the same Golgi subcompartments is in agreement with the biochemical findings (11) (12) (13) 45) and is not inconsistent with their coordinate action during N-glycoprotein processing (22, 31) .
It appears that N-glycoprotein processing by these mannosidases occurs largely in more distal Golgi cisternae in the cell types examined. Alternatively, processing in these cells could be initiated in the cis-Golgi cisternae by a different enzyme. For instance, an endomannosidase activity has been demonstrated in the rat liver Golgi that can provide an alternative processing route to Man I for glycoproteins that enter the Golgi complex still bearing glucose residues (24, 25, 29) . In the case of the final mannose (Man ID trimming the possibility exists that it is partially or totally carded out in an earlier Golgi compartment by another enzyme such as the al,3/od,6-mannosidase described in BHK cells (28) .
It is also possible that relatively few copies of Man I and Man II, below the level of detection by immunocytochemistry, are present and enzymatically active in earlier (cis) Golgi cisternae in the cell types we have studied. In fact, in rat myeloma cells and hepatocytes we have detected Man I and II in all Golgi compartments including the cis-cisternae.
Localization of Man I and H on the Cell Surface
Both Man I and II have been immunolocalized on the cell surface of duodenal and colonic enterocytes and pancreatic acinar cells. Although some of the cell surface immunoreactivity with Man II may be due to cross-reactivity of the antibody with carbohydrate epitopes, two lines of evidence indicate that the enzyme is found at the cell surface. First, antibody that had been affinity purified on deglycosylated Man II reacts with cell surface epitopes of both enterocytes and pancreatic acinar cells. Second, cell surface staining is detected on chemically deglycosylated sections. Therefore we conclude that Golgi mannosidases are in fact expressed at the plasma membrane of certain cell types.
There are now an increasing number of cases where Golgi enzymes involved in glycoprotein processing have been localized at the plasma membrane of individual cell types, including /31,4-galactosyltransferase (47, 50), c~2,6-sialyltransferase (51) and N-acetylgalactosaminyltransferase (2). Furthermore, a fucosyltransferase (37) and an ot-o-mannosidase activity have recently been described on the plasma membrane of spermatozoa (57). Usually a role in either cellsubstratum and/or cell-to-cell recognition processes has been proposed for these cell surface-associated enzymatic activities. However, before any function can be assigned to Golgi Man I and II at the plasma membrane it must be determined if they are enzymatically active at this location.
General Comments on Markers of Golgi Subcompartments
Thus far the number of Golgi markers that are available are quite limited. Relatively few Golgi-specific antibodies have been generated that are useful for this purpose. The list is limited to a few glycoprotein processing enzymes, galac- lines (Farquhar, M. G., unpublished data). Our present immunoelectron microscopic observations confirm that in all cell types examined Man II represents a valid intracellular marker for the Golgi complex for immunofluorescence assays. However, neither it nor Man I can be taken as a marker for any specific Golgi subcompartment since its distribution within the Golgi varies from one cell type to another. Typically both enzymes were found to be most concentrated in middle and transGolgi cisternae.
